| Spirig HealthCare AG - Pramipexol Spirig HC retard 3.0 mg, Retardtabletten |
| 70426 | | 04 | | Pramipexol Spirig HC retard 3.0 mg | | Retardtabletten | | N04BC05 | | Pramipexole | | 10.02.2026 | | |
|
| Composition |
| pramipexoli dihydrochloridum monohydricum 3 mg corresp. pramipexolum 2.1 mg, hypromellosum, calcii hydrogenophosphas, magnesii stearas, silica colloidalis anhydrica pro compresso. |
| Packungsbestandteile |
| Delayed release tablets | | | | | Active Agent | Dose |
|---|
| Pramipexol Dihydrochloride Monohydrate | 3 mg correspond Pramipexol 2.1 mg |
| | BAG: Active Agent | Dose |
|---|
| Pramipexol Dihydrochloride Monohydrate | 3 mg |
| | | | Inactive agents |
|---|
| Calcium Hydrogen Phosphate | | Hypromellosum | | Magnesii Stearas | | Silica Colloidalis Anhydrica pro Compresso |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | 30 | 93.56 | 118.15 | B | SL | No |
|
